Top Markets
#1 ONFA ONFA +219.25%
#2 Noon Noon +41.33%
#3 Doge Strategy Doge Strategy +38.28%
#4 StakeStone StakeStone +33.57%
#5 Bedrock Bedrock +22.06%
#6 Echelon Prime Echelon Prime +15.67%
#7 Trusta AI Trusta AI +15.34%
#8 PlaysOut PlaysOut +13.12%
#9 BLOCKv BLOCKv +13.10%
#10 PUMPCADE PUMPCADE +12.72%
Coin of the day
ONFA ONFA
Settings
Language
ENGLISH
Currency
USD
Theme
Johnson & Johnson Johnson & Johnson

Johnson & Johnson

JNJ
Rank in Stocks #18
Johnson & Johnson, together with its subsidiaries, researches and develops,... Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; TYLENOL acetaminophen products; SUDAFED cold, flu, and allergy products; BENADRYL and ZYRTEC allergy products; MOTRIN IB ibuprofen products; NICORETTE smoking cessation products; and PEPCID acid reflux products. It also offers STAYFREE and CAREFREE sanitary pads; o.b. tampons; adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. It serves general public, retail outlets, and distributors. The company's Pharmaceutical segment offers products for rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; HIV/AIDS and COVID-19 infectious diseases; mood disorders, neurodegenerative disorders, and schizophrenia; prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; thrombosis, diabetes and macular degeneration; and pulmonary arterial hypertension. This segment serves retailers, wholesalers, distributors, hospitals, and healthcare professionals directly for prescription use. Its MedTech segment provides electrophysiology products to treat cardiovascular diseases; neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery under the ACUVUE brand. This segment serves wholesalers, hospitals, and retailers. The company was founded in 1886 and is based in New Brunswick, New Jersey.
Share Price
$240.45
Market Cap
$579.46B
Change (1 day)
0.51%
Change (1 year)
46.88%
Country
US
Trade Johnson & Johnson (JNJ)

Category

Healthcare
Number of shares outstanding for Johnson & Johnson (JNJ)
Number of shares outstanding as of December 2025: 2.43B
According to Johnson & Johnson latest financial reports and stock price the company's current number of shares outstanding is 2.43B. At the end of December 2024 the company had 2.41B shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Johnson & Johnson (JNJ) from 2000 to 2026
Shares Outstanding at the end of each year
Year Shares Outstanding Change
2026 (TTM) 2.43B 0.00%
2025 2.43B 0.88%
2024 2.41B -4.98%
2023 2.53B -3.63%
2022 2.63B -0.13%
2021 2.63B 0.00%
2019 2.63B -1.12%
2018 2.66B -0.75%
2017 2.68B -0.89%
2016 2.71B -1.77%
2015 2.76B -1.01%
2014 2.78B -1.33%
2013 2.82B 1.52%
2012 2.78B 1.99%
2011 2.72B -0.50%
2010 2.74B -0.79%
2009 2.76B -1.85%
2008 2.81B -2.46%
2007 2.88B -1.93%
2006 2.94B -1.23%
2005 2.98B 0.28%
2004 2.97B 0.00%
2003 2.97B -1.02%
2002 3.00B -1.07%
2001 3.03B 1.25%
2000 2.99B 0.00%
Shares Outstanding for similar companies or competitors
Company Shares Outstanding Difference Country
Eli Lilly Eli Lilly
Eli Lilly
LLY.US
 898.00M -63.02%
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
 1.78B -26.69%
US
Novartis AG Novartis AG
Novartis AG
NVS.US
 1.91B -21.23%
CH
AstraZeneca PLC AstraZeneca PLC
AstraZeneca PLC
AZN.US
 3.10B 27.65%
GB
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
 2.49B 2.52%
US